Brain volumes, cognitive impairment, and conjugated equine estrogens

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 64, Issue 12, 2009, Pages 1243-1250

  Espeland, Mark A ^a   Tindle, Hilary A ^b   Bushnell, Cheryl A ^a   Jaramillo, Sarah A ^a   Kuller, Lewis H ^c   Margolis, Karen L ^d   Mysiw, W Jerry ^e   Maldjian, Joseph A ^a   Melhem, Elias R ^f   Resnick, Susan M ^g  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Hormone therapy; Magnetic resonance imaging; Women's health

Indexed keywords

EQUIDAE;

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

AGE; AGED; AGING; ANALYSIS OF VARIANCE; ARTICLE; BRAIN; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; METHODOLOGY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL MODEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; BRAIN; COGNITION DISORDERS; DEMENTIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MEDROXYPROGESTERONE ACETATE; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; POSTMENOPAUSE; PROGNOSIS; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC;

EID: 75949118719     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glp128     Document Type: Article

References (34)

1. Shumaker S, Legault C, Rapp S, et al. The effects of estrogen plus progestin on the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women ' s Health Initiative Memory Study. JAMA. 2003;289:2651-2662. (Pubitemid 37430136)
2. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women ' s Health Initiative Memory Study. JAMA. 2004;291:2947-2958.
3. Resnick SR, Espeland MA, Jaramillo SA, et al. Effects of postmeno-pausal hormone therapy on regional brain volumes in older women: the Women ' s Health Initiative Magnetic Resonance Imaging Study (WHIMS-MRI). Neurology. 2009;72:135-142.
4. Coker LH, Hogan PE, Bryan NR, et al. The effects of postmenopausal hormone therapy on volumetric sub-clinical cerebrovascular disease: the Women ' s Health Initiative Memory Study-Magnetic Resonance Imaging Study (WHIMS-MRI). Neurology. 2009;72:125-134.
5. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women. JAMA. 2004;291:2959-2968.
6. Shumaker SA, Reboussin BA, Espeland MA, et al. The Women's Health Initiative Memory Study: a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials. 1998;19:604-621
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: principal results from the Women ' s Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
8. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004;291:1701-1712.
9. Jaramillo SA, Felton D,Andrews LA, et al. Enrollment in a brain magnetic resonance study: results from the Women ' s Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI). Acad Radiol. 2007;14:603-612.
10. Teng EL, Chui HC. The Modifi ed Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-318.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
12. Lao Z, Shen D, Liu D, et al. Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol. 2008;15:300-313.
13. Whitwell JL, Crum WR, Watt HC, Fox NC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol. 2001;22: 1483-1489
14. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19:61-109.
15. Hersch AL, Stefanick ML, Stafford RS. National use of postmeno-pausal hormone therapy: annual trends and response to recent evidence. JAMA. 2003;91:47-53.
16. Rossouw JE, Prentice RL, Manson KE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465-1477.
17. Tanapat P, Hastings NB, Reeves AJ, Gould E. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J Neurosci. 1997;19:5792-5801.
18. Ormerod BK, Lee TT, Galea LA. Estradiol initially enhances but subsequently suppresses (via adrenal steroids) granule cell proliferation in the dentate gyrus of adult female rats. J Neurobiol. 2003;55: 247-260.
19. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002;3:433-442.
20. Banasr M, Hery M, Brezun JM, Daszuta A. Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus. Eur J Neurosci. 2001;14:1417-1424.
21. Galea LA, Spritzer MD, Barker JM, Pakluski JL. Gonadal hormone modulation of hippocampal neurogenesis in the adult. Hippocampus 2006;16:225-232.
22. Spencer JL, Waters EM, Romeo RD, et al. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroen-docrinol. 2008;29:219-237.
23. Kempermann G, Song H, Gage FH. Neurogenesis in the adult hippocampus, in adult neurogenesis. In: Gage FH, Kempermann G, Song H, eds. Adult Neurogenesis. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2008:159-174.
24. Lord C, Buss C, Lupien SJ, Pruessner JC. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging. 2008;29:95-101.
25. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 1992;17: 485-495.
26. Erickson KI, Colcombe SJ, Elavsky S, et al. Interactive effects of fi tness and hormone treatment on brain health in postmenopausal women. Neurobiol Aging. 2007;28:179-185.
27. Matthews K, Cauley J, Yaffe K, Zmuda JM. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc. 1999;47:518-523. (Pubitemid 29215577)
28. Wiseman RM, Saxby BK, Burton EJ, et al. Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology. 2004;23:1892-1897.
29. Korf ES, White LR, Launer LJ. Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 2004;44:29-34.
30. Walstein SE, Brown JR, Maier KJ, Katzel LI. Diagnosis of hypertension and high blood pressure levels negatively affect cognitive function in older adults. Ann Behav Med. 2005; 29: 174-180.
31. Rozovsky I, Hoving S, Anderson CP, et al. Equine estrogens induce apolipoprotein E and glial fi brillary acidic protein in mixed glial cultures. Neurosci Lett. 2002;323:191-194.
32. Dhandapani KM, Wade FM, Mahesh VB, Brann DW. Astrocyte-derived transforming growth factor-b mediates the neuroprotective effects of 17 b-estradiol involvement of nonclassical genomic signaling pathways. Endocrinology. 2005;146:2749-2757.
33. Colton CA, Brown CM, Vitek MP. Sex steroids, APOE genotype and the innate immune system. Neurobiol Aging. 2005;26:363-372.
34. Hebert LE, Scherr PA, Beckett LA, et al. Age-specifi c incidence of Alzheimer ' s disease in a community population. JAMA. 1995;273: 1354-1359